Dominik Duscher1, Zeshaan N Maan2, Anna Luan2, Matthias M Aitzetmüller3, Elizabeth A Brett2, David Atashroo2, Alexander J Whittam2, Michael S Hu2, Graham G Walmsley4, Khosrow S Houschyar5, Arndt F Schilling6, Hans-Guenther Machens3, Geoffrey C Gurtner2, Michael T Longaker4, Derrick C Wan2. 1. Division of Plastic Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA; Department of Plastic and Hand Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. Electronic address: dominik.duscher@mri.tum.de. 2. Division of Plastic Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. 3. Department of Plastic and Hand Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. 4. Division of Plastic Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA. 5. Division of Plastic Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA; Department of Plastic and Hand Surgery, Burn Unit, Trauma Center Bergmannstrost Halle, Germany. 6. Department of Plastic and Hand Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Division for Research and Development, Department for Traumatology, Orthopedic and Plastic Surgery, Göttingen University, Germany.
Abstract
BACKGROUND AIMS: Regenerative medicine employs human mesenchymal stromal cells (MSCs) for their multi-lineage plasticity and their pro-regenerative cytokine secretome. Adipose-derived mesenchymal stromal cells (ASCs) are concentrated in fat tissue, and the ease of harvest via liposuction makes them a particularly interesting cell source. However, there are various liposuction methods, and few have been assessed regarding their impact on ASC functionality. Here we study the impact of the two most popular ultrasound-assisted liposuction (UAL) devices currently in clinical use, VASER (Solta Medical) and Lysonix 3000 (Mentor) on ASCs. METHODS: After lipoaspirate harvest and processing, we sorted for ASCs using fluorescent-assisted cell sorting based on an established surface marker profile (CD34+CD31-CD45-). ASC yield, viability, osteogenic and adipogenic differentiation capacity and in vivo regenerative performance were assessed. RESULTS: Both UAL samples demonstrated equivalent ASC yield and viability. VASER UAL ASCs showed higher osteogenic and adipogenic marker expression, but a comparable differentiation capacity was observed. Soft tissue healing and neovascularization were significantly enhanced via both UAL-derived ASCs in vivo, and there was no significant difference between the cell therapy groups. CONCLUSIONS: Taken together, our data suggest that UAL allows safe and efficient harvesting of the mesenchymal stromal cellular fraction of adipose tissue and that cells harvested via this approach are suitable for cell therapy and tissue engineering applications.
BACKGROUND AIMS: Regenerative medicine employs human mesenchymal stromal cells (MSCs) for their multi-lineage plasticity and their pro-regenerative cytokine secretome. Adipose-derived mesenchymal stromal cells (ASCs) are concentrated in fat tissue, and the ease of harvest via liposuction makes them a particularly interesting cell source. However, there are various liposuction methods, and few have been assessed regarding their impact on ASC functionality. Here we study the impact of the two most popular ultrasound-assisted liposuction (UAL) devices currently in clinical use, VASER (Solta Medical) and Lysonix 3000 (Mentor) on ASCs. METHODS: After lipoaspirate harvest and processing, we sorted for ASCs using fluorescent-assisted cell sorting based on an established surface marker profile (CD34+CD31-CD45-). ASC yield, viability, osteogenic and adipogenic differentiation capacity and in vivo regenerative performance were assessed. RESULTS: Both UAL samples demonstrated equivalent ASC yield and viability. VASER UAL ASCs showed higher osteogenic and adipogenic marker expression, but a comparable differentiation capacity was observed. Soft tissue healing and neovascularization were significantly enhanced via both UAL-derived ASCs in vivo, and there was no significant difference between the cell therapy groups. CONCLUSIONS: Taken together, our data suggest that UAL allows safe and efficient harvesting of the mesenchymal stromal cellular fraction of adipose tissue and that cells harvested via this approach are suitable for cell therapy and tissue engineering applications.
Authors: A Sterodimas; F Boriani; E Magarakis; B Nicaretta; L H Pereira; Y G Illouz Journal: Eur Rev Med Pharmacol Sci Date: 2012-03 Impact factor: 3.507
Authors: Nicholas J Panetta; Deepak M Gupta; Matthew D Kwan; Derrick C Wan; George W Commons; Michael T Longaker Journal: Plast Reconstr Surg Date: 2009-07 Impact factor: 4.730
Authors: Jennifer H Choi; Jeffrey M Gimble; Kyongbum Lee; Kacey G Marra; J Peter Rubin; James J Yoo; Gordana Vunjak-Novakovic; David L Kaplan Journal: Tissue Eng Part B Rev Date: 2010-08 Impact factor: 6.389
Authors: Dominik Duscher; Anna Luan; Robert C Rennert; David Atashroo; Zeshaan N Maan; Elizabeth A Brett; Alexander J Whittam; Natalie Ho; Michelle Lin; Michael S Hu; Graham G Walmsley; Raphael Wenny; Manfred Schmidt; Arndt F Schilling; Hans-Günther Machens; Georg M Huemer; Derrick C Wan; Michael T Longaker; Geoffrey C Gurtner Journal: J Transl Med Date: 2016-05-06 Impact factor: 5.531
Authors: Dominik Duscher; David Atashroo; Zeshaan N Maan; Anna Luan; Elizabeth A Brett; Janos Barrera; Sacha M Khong; Elizabeth R Zielins; Alexander J Whittam; Michael S Hu; Graham G Walmsley; Michael S Pollhammer; Manfred Schmidt; Arndt F Schilling; Hans-Günther Machens; Georg M Huemer; Derrick C Wan; Michael T Longaker; Geoffrey C Gurtner Journal: Stem Cells Transl Med Date: 2015-12-23 Impact factor: 6.940
Authors: Elizabeth M Meier; Bin Wu; Aamir Siddiqui; Donna G Tepper; Michael T Longaker; Mai T Lam Journal: Plast Reconstr Surg Glob Open Date: 2016-09-16
Authors: Maria Eugenia Fernández-Santos; Mariano Garcia-Arranz; Enrique J Andreu; Ana Maria García-Hernández; Miriam López-Parra; Eva Villarón; Pilar Sepúlveda; Francisco Fernández-Avilés; Damian García-Olmo; Felipe Prosper; Fermin Sánchez-Guijo; Jose M Moraleda; Agustin G Zapata Journal: Front Immunol Date: 2022-06-09 Impact factor: 8.786
Authors: Ursula Hopfner; Matthias M Aitzetmueller; Philipp Neßbach; Michael S Hu; Hans-Guenther Machens; Zeshaan N Maan; Dominik Duscher Journal: Stem Cells Int Date: 2018-12-19 Impact factor: 5.443